|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: GENEREX BIOTECHNOLOGY CORP, 10-Q, 2000-12-15 |
Next: MANAGED HIGH YIELD PLUS FUND INC, PRES14A, 2000-12-15 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUL-31-2001
<PERIOD-END> OCT-31-2000
<CASH> 11,915,573
<SECURITIES> 17,702,001
<RECEIVABLES> 15,587
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 29,883,960
<PP&E> 2,977,534
<DEPRECIATION> 222,046
<TOTAL-ASSETS> 36,710,775
<CURRENT-LIABILITIES> 1,419,635
<BONDS> 686,162
0
1
<COMMON> 57,874,762
<OTHER-SE> (54,118)
<TOTAL-LIABILITY-AND-EQUITY> 36,710,775
<SALES> 0
<TOTAL-REVENUES> 1,000,000
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 2,344,532
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (19,620)
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,144,207)
<EPS-BASIC> (0.07)
<EPS-DILUTED> (0.07)
</TABLE>
|
|